Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,165 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Response to sumatriptan in headache of MELAS syndrome.
Iizuka T, Sakai F, Endo M, Suzuki N. Iizuka T, et al. Among authors: suzuki n. Neurology. 2003 Aug 26;61(4):577-8. doi: 10.1212/01.wnl.0000078931.87815.b3. Neurology. 2003. PMID: 12939448 No abstract available.
[Migraine and stroke].
Suzuki N. Suzuki N. Rinsho Shinkeigaku. 2006 Nov;46(11):899-901. Rinsho Shinkeigaku. 2006. PMID: 17432214 Japanese.
Efficacy and safety of fremanezumab for chronic migraine prevention: Multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in Japanese and Korean patients.
Sakai F, Suzuki N, Kim BK, Igarashi H, Hirata K, Takeshima T, Ning X, Shima T, Ishida M, Iba K, Kondo H, Koga N. Sakai F, et al. Among authors: suzuki n. Headache. 2021 Jul;61(7):1092-1101. doi: 10.1111/head.14169. Epub 2021 Jul 29. Headache. 2021. PMID: 34324700 Free PMC article. Clinical Trial.
Efficacy and safety of fremanezumab for episodic migraine prevention: Multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in Japanese and Korean patients.
Sakai F, Suzuki N, Kim BK, Tatsuoka Y, Imai N, Ning X, Ishida M, Nagano K, Iba K, Kondo H, Koga N. Sakai F, et al. Among authors: suzuki n. Headache. 2021 Jul;61(7):1102-1111. doi: 10.1111/head.14178. Epub 2021 Jul 29. Headache. 2021. PMID: 34323290 Free PMC article. Clinical Trial.
A long-term open-label safety study of galcanezumab in Japanese patients with migraine.
Hirata K, Takeshima T, Sakai F, Tatsuoka Y, Suzuki N, Igarashi H, Nakamura T, Ozeki A, Yamazaki H, Skljarevski V. Hirata K, et al. Among authors: suzuki n. Expert Opin Drug Saf. 2021 Jun;20(6):721-733. doi: 10.1080/14740338.2021.1866536. Epub 2021 Jan 4. Expert Opin Drug Saf. 2021. PMID: 33393835 Free article. Clinical Trial.
6,165 results